NCT04611126 2025-08-12T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian CancerHerlev HospitalPhase 1/2 Terminated6 enrolled 11 charts
NCT03311334 2024-04-18A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid TumorsSumitomo Pharma America, Inc.Phase 1/2 Terminated47 enrolled 11 charts
NCT03824704 2023-06-12A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)pharmaand GmbHPhase 2 Terminated1 enrolled 7 charts